ABBV

ABBV

AbbVie Inc
Biotechnology
$207.94 -2.10% As of Apr 11, 6:07 AM
Loading chart...
Interactive chart powered by TradingView

Technical Analysis

ABBV Tests Lower Support as EMAs Roll Over at $207.94

Bearish
Apr 11, 2026 at 6:07 AM • $207.94 (-2.10%)

The stock of AbbVie Inc (ABBV) dropped 2.10% to close at $207.94 on April 11.

The technical picture is mixed:

Moving Averages Bearish EMA structure persists with price below the 9-day ($210.22) and 21-day ($212.97).
Momentum RSI at 41.9 is in neutral territory but trending higher. MACD reads -3.33 against its -3.69 signal line (bullish).
Volatility Bollinger Band width at 9.8% indicates low volatility.

Despite the bearish EMA structure, bullish MACD divergence suggests patient buyers may find opportunity near $200.57.

Support sits at $200.57 with resistance at $221.21.

ABBV Slips Below Moving Averages, Testing $207.94

Bearish
Apr 10, 2026 at 9:00 PM • $207.94 (-2.10%)

Positive Divergence: ABBV MACD Turns at $212.40

Bullish
Apr 10, 2026 at 2:31 AM • $212.40 (+0.39%)

MACD Turns Bullish for ABBV at $212.40

Bullish
Apr 9, 2026 at 9:00 PM • $212.40 (+0.39%)

ABBV Upside Momentum Accelerates at $211.59

Bullish
Apr 8, 2026 at 9:00 PM • $211.59 (+2.53%)
Systematic technical analysis • Updated daily after market close
Exclusive Offer

Get Trade Alerts

Receive disciplined options trade ideas with entries, targets & risk management.

Use code:
HEADSTART50
50% off your first month
Claim Offer Try Scanner

Market Summary

Current Price $207.94
Daily Change -2.10%
Sentiment Bearish
Sector Biotechnology
Last Updated Apr 11

Related Stocks

AMGN
AMGN
Amgen Inc
BIIB
BIIB
Biogen Inc
MRNA
MRNA
Moderna Inc
REGN
REGN
Regeneron Pharmaceuticals Inc
VRTX
VRTX
Vertex Pharmaceuticals Inc
Disclaimer: This analysis is for educational purposes only. Options trading involves substantial risk. Past performance does not guarantee future results.